Medical articles today

/* 728x15, */

Clue To Improving Prognosis In Acute Emotions Failure - Higher quality Treatment Selection And Improved Therapies

/* 468x60, */

Today, acute love failure represents the most popular dialectics for hospitalisation in the over-65 population. Although infirmary care improves symptoms in the first 24 hours after admission in around 50% of these patients, acute heart failure events even last associated with a enhanced than 50% mortality and rehospitalisation ratio at 6-12 months. "Indeed," says Professor Marco Metra from the Cardiology Department of the University of Brescia, Italy, "it is the extremely quick charge of symptoms and the entail for urgent therapy which characterise the condition."1,2
Treatments in acute heart failure, he adds, have not undergone any enormous silver in recent decades, despite the entail of heart failure's increasing prevalence and vast personal and accepted impact. Professor Metra said that treatments are still based on loop diuretics (furosemide), peripheral vasodilators (nitrates) and inotropic agents. Still the else recently approved treatments, he added, such as levosimendan in Europe and nesiritide in the USA, accept been associated with uncertain item on outcomes in randomised trials. "So hospitalisations for acute heart failure are much associated with big mortality and rehospitalisation rates," he says. "The burden is tremendous for of the large number of patients involved, their flat broke prognosis and the costs of the treatment."
In a presentation at Passion Failure Congress 2009 Professor Metra defined two major pathways along which this difficulty might be reduced and treatment improved:
  • More suitable choice of treatments. To date, he said, therapy in acute affection failure has been administered with little carefulness to the clinical presentation of everyone patient. Guidelines on heart failure issued by the European Society of Cardiology in 2008 define feelings failure as a heterogeneous condition and reccomend that discrepant therapies are used on the justification of clinical presentation; for example, patients with fluid overload should undergo fluid removal through diuretics or other means, patients with flying blood force should catch mainly vasodilators, and patients with low cardiac output should be treated with inotropic agents to improve the force of the heart muscle's contraction.3
  • Improved therapies. Countless recent agents are currently under development, said Professor Metra, which contain adenosine type 1 receptors antagonists to augment the diuretic baggage of furosemide and increase renal blood flow, brand-new vasodilators with different mechanisms of action, and new inotropic agents.
"Better treatment selection and the addition of new agents give us some endurance that we will last of all be able to emend the symptoms and prognosis of such a extensive patient population as that suffering from acute heart failure," says Professor Metra. However, he also emphasised that pressing therapy is one of the key recommendations of the latest European guidelines.
Heart Failure Congress 2009 is organised by the European Society of Cardiology and Heart Failure Partnership of the ESC, and takes area from 30 May to 2 Jun at the Palais Acropolis, Nice, France.
Metra M. Acute heart failure: prognostic variables
European Homeland of Cardiology; Heart Failure Association of the ESC (HFA); European Society of Intensive Concern Medicine (ESICM). ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. Eur J Heart Fail 2008; 10: 933-989.
Information on the scientific programme is available at
ESC Press Duty
European Society of Cardiology
/* 468x60, */


failure, heart failure, failure higher, emotions failure, failure congress, failure represents, failure administered, failure heterogeneous, failure events, failure issued
/* 160x600, */
Medical articles today © Padayatra Dmitriy
Designer Dimitrov Dmytriy